|
Development of targeted genotyping methods for improved drug resistance surveillance |
mPLEXABR |
June 1, 2014 |
|
Bacterial diseases, Transversal activities in applied genomics, Veterinary bacteriology |
antibiotic resistance, genetic determinant, multiplex identification, beta-lactamases, fluoroquinolones, enterobacteriaceae |
|
Human genomic biomarker RTqPCR array for optimised and mechanistically-based genotoxicity assessment |
GENOMARK |
May 1, 2014 |
December 31, 2018 |
Risk and health impact assessment, Transversal activities in applied genomics |
toxicogenetics, transcriptomics, DNA damage, genotoxicity tests, gene expression profiling, in vitro, 3R, alternative method |
|
OIE Laboratory Twinning project for foot-and-mouth disease diagnostic laboratory capacity building in Nigeria |
OIE Twinning FMD |
May 1, 2014 |
April 30, 2018 |
Exotic and vector-borne diseases |
foot-and-mouth disease, disease control, diagnostics, staff training, quality control, biosafety, Nigeria |
|
Protective Effect of South African Plants on Mycotoxin-Induced Mutagenicity and Toxicity |
Z.-Afrika |
April 1, 2014 |
February 28, 2018 |
Risk and health impact assessment |
Mycotoxin, mutagenicity, antimutagenicity, Vitotox test, comet assay, micronucleus test |
|
Modeling the absorption of cadmium in leaf and root crops |
FoodCad |
March 1, 2014 |
February 29, 2016 |
Trace elements and nanomaterials, Organic contaminants and additives |
cadmium, spinach, carrots, modeling, root uptake |
|
Development of a prioritisation strategy for hazard characterisation of substances migrating from printed paper and board food contact materials based on their genotoxicity |
PRIMISTRA |
February 17, 2014 |
February 14, 2018 |
Risk and health impact assessment, Organic contaminants and additives |
food contact materials, printing inks, paperboard, genotoxicity, gene mutation, in silico, in vitro, 3R |
|
Expert Support for the assessment of applications for certificates of conformity, the monitoring of technological developments and research into health effects on wireless technology |
LNE-2014-2022 |
February 3, 2014 |
June 30, 2024 |
Risk and health impact assessment |
mobile phone, radiofrequency radiation, non ionising radiation, biological effects, in vitro, in vivo |
|
Cancer Control |
CanCon |
February 1, 2014 |
March 1, 2017 |
Cancer centre |
cancer, cancer control |
|
Antigenic drift in the surface proteins of the mumps virus and its impact on vaccine efficacy |
Bofvax |
January 1, 2014 |
December 31, 2018 |
Viral diseases |
Mumps, vaccination, virus-neutralisation test, immunity, T cell, B cell, epitopes, antigenicity |
|
A 12-years trend analysis of candidemia in Belgium: incidence, drug resistance and antifungal consumption |
CglabrataR |
January 1, 2014 |
June 30, 2018 |
Mycology and aerobiology , Healthcare-associated infections and antimicrobial resistance |
candidemia, antifungal resistance, antifungal consumption, nosocomial diseases, yeast, fungi, mycology |
|
Outbreak Support Team |
OST |
November 21, 2013 |
|
Healthcare-associated infections and antimicrobial resistance |
outbreak support team, OST, multidrug resistant organisms, MDRO, antibiotic resistance, chronic care institution, residential care center, ziekenhuis, infection prevention and control, IPC |
|
Development of an integrated approach based on validated and standardised methods to support the implementation of the EC recommendation for a definition of nanomaterial |
NanoDefine |
November 1, 2013 |
October 31, 2017 |
Trace elements and nanomaterials |
nanomaterials, EC definition, TEM, dispersion protocols, software validation |
|
Use of proteomics for the quality control of intravenous immunoglobulins |
PLPROT |
October 1, 2013 |
September 30, 2017 |
Quality of vaccines and blood products |
proteomics, quality control, immunoglobulins, plasma derivatives |
|
Tick-borne encephalitis virus eco-epidemiology: study of the prevalence and pathogenesis in rodents and wild animals |
TBEV Epi |
October 1, 2013 |
December 31, 2019 |
Viral diseases, Epidemiology of infectious diseases, Quality of vaccines and blood products |
tick-borne encephalitis virus, ticks, sentinel, seroprevalence, rodents |
|
Accelerated Development of Vaccine Benefit-Risk Collaboration in Europe |
ADVANCE |
October 1, 2013 |
September 30, 2018 |
Epidemiology of infectious diseases, Quality of vaccines and blood products |
vaccination, immunisation, preventive, therapeutical, pharmacovigilance, epidemiology, surveillance, risk/benefit assesment, patients |
|
Improvement of anti-TB treatment by study of antibiotic resistance mechanisms |
TB drugs |
June 24, 2013 |
|
Bacterial diseases |
mycobacterium tuberculosis, antibiotic resistance, genetic changes, protein structure, mutants, DNA sequencing |
|
A common European approach to the regulatory testing of Manufactured Nanomaterials |
NANoREG |
March 1, 2013 |
February 28, 2017 |
Trace elements and nanomaterials |
nanomaterials, EC definition, TEM, inter laboratory comparison, SOP validation |
|
The Orphanet Encyclopedia, Terminology and Website in Dutch |
OrphaDutch |
January 1, 2013 |
|
Health services research |
rare diseases and disorders, orphan drugs, world wide web, accessibility of Health Services, terminology, Snomed-CT, nomenclature, disease coding |
|
Virus-host interplay at the early stages of infection |
BELVIR |
October 1, 2012 |
September 30, 2017 |
Trace elements and nanomaterials |
myxoviruses, glycoproteins, TEM, attachment-fusion, mucus, GFP |
|
Food contaminants |
CONTAM |
July 2, 2012 |
June 30, 2024 |
|
food contaminants, risk assessment, consumer exposure |
|
Bioavailability and transformation of arsenic from food: role of food preparation, preservation and digestion |
BIOTRAs |
February 1, 2012 |
January 31, 2015 |
Trace elements and nanomaterials |
arsenic, speciation, bioaccessibility, risk evaluation, exposure, food preparation |
|
Clinical validation of human papillomavirus assays |
VALGENT |
January 15, 2012 |
|
Cancer centre |
Human papillomavirus, cervical cancer, cervical cancer screening, diagnostic test accuracy, test validation, quality control |
|
Communication with communities |
Communication with communities |
January 2, 2012 |
|
Infectious diseases in humans, Laboratory of medical microbiology (LMM) |
Laboratory, Medical Microbiology, Belgian Communities, infectious diseases, medical advice, logistical support, sample management, data on infectious diseases |
|
Central Registry Rare Diseases |
CRRD |
January 1, 2012 |
|
Health services research |
patient registry, rare diseases, epidemiology, genetic centre, ORPHA-code, Healthdata.be, clinical trial recruitment, common data set |
|
Severe Acute Respiratory Infection surveillance by a sentinel network of hospitals |
SARI |
January 1, 2012 |
|
Viral diseases, Epidemiology of infectious diseases |
SARI surveillance, severe acute respiratory infections, sentinel, Influenza |
|
European Surveillance of Antimicrobial Consumption Network |
ESAC-Net |
November 30, 2011 |
|
Healthcare-associated infections and antimicrobial resistance |
surveillance, antimicrobial consumption, community, hospital |
|
Clinical Biology LMM |
LMM |
June 1, 2011 |
|
Infectious diseases in humans, Laboratory of medical microbiology (LMM) |
Laboratory, Medical Microbiology, clinical biology, test validation, quality control, communication improvement, clinical relevance optimisation, medical collaboration, medical contacts, Belgian Communities, medical expert advice |
|
Quality indicators for infection prevention and control in acute hospitals |
NSIH_QI |
January 1, 2011 |
|
Healthcare-associated infections and antimicrobial resistance |
quality indicators, infection prevention and control, acute hospitals |
|
Intradermal rabies vaccination trials in humans: towards shorter and cheaper rabies vaccination |
Intradermo |
January 1, 2011 |
December 31, 2019 |
Viral diseases |
rabies, intradermal vaccination, clinical trials |
|
Point prevalence survey of healthcare-associated infections and antimicrobial use in acute care hospitals |
ECDC-PPS |
January 1, 2011 |
|
Healthcare-associated infections and antimicrobial resistance |
nosocomial infection, healthcare-associated infection, antibiotics, acute hospitals |
